Attenuated FBXW7 and PPARA in advanced NASH patients along with uncontrolled ERRα activity synergistically create a vicious cycle in part through lipotoxicity and exacerbate the imbalance of hepatic and systemic homeostasis especially upon metabolic stress, underlying NASH progression. Here, ESRRA is linked to metabolic dysfunction-associated steatohepatitis.